Tetravac, suspension injectable

7680006120037 CH-612 Injektionssuspension

Associated product:

TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
Tetravac, suspension injectable
Tetravac, suspension injectable
Tetravac, suspension injectable
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/05/2024
Summary of Product Characteristics
Français
08/05/2024
Summary of Product Characteristics
Italien
08/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 UI Substance Wirkstoff (Principe actif)
(N/A)
40.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance WIIS
(N/A)
25.0 UG Substance WIIS
(N/A)
29.0 U Substance Wirkstoff (Principe actif)
(N/A)
7.0 U Substance Wirkstoff (Principe actif)
(N/A)
26.0 U Substance Wirkstoff (Principe actif)
(N/A)
0.3 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
12.5 UG Substance HBESI
(N/A)
- Substance HBESI
(N/A)
2.0 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK

Reimbursement information

Public price
CHF 38.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/04/2000

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
612
Drug name
Tetravac, suspension injectable
Galenic form
INJFS
ATC Code
J07CA02
Authorization status
Z
Dispensing category
B
First authorization
18/08/1999
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Diphtherie, Tetanus, Pertussis und Poliomyelitis, ab dem vollendeten 2. Lebensmonat bis zum vollendeten 7. Lebensjahr

Package details

Description (FR)
TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
Description (DE)
TETRAVAC Inj Susp mit 1 Nadel Fertspr 0.5 ml
Market launch
18/08/1999
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (2)

TETRAVAC susp inj av 2 aiguilles ser pré 0.5 ml
None None
GTIN: 7680006120013
Not in V1
None
None None
GTIN: None
Not in V1